Ischemic stroke Market Overview Analysis By Type, By Indication, By Region, By Country: Drivers, Trends and Forecast to 2032

 

Research by the World Health Organization (WHO) states that around 17 million deaths have been noticed annually due to strokes. The higher mortality rate associated with strokes showcases an impending need for new and innovative drugs and diagnostic devices. As per the latest report released by Market Research Future (MRFR), the Global Ischemic Stroke Market Trends is expected to attain a CAGR of approximately 7.8% during the forecast period between 2023 and 2032. 

Ischemic Strokes occur when an artery or blood vessel supplying blood to the brain is blocked. The brain is dependent on the arteries to bring fresh blood from the lungs and heart. A blockage in the same causes ischemic stroke. The underlying reason behind such obstruction is the development of fatty deposits lining the vessel walls, also known as atherosclerosis. 

The evolving lifestyle of individuals, prevalence of diabetes, increasing ageing population, and high tobacco usage are the major factors driving the market. Additionally, the increasing demand for minimally invasive procedures and advancements in surgical procedures are some of the key factors accelerating the growth of the global market. However, the high cost associated with such surgical procedures and the excessive medicinal usage for the treatment of the condition is reported as a major hindrance to the market growth. 

Competitive Landscape

The Global Ischemic Stroke Market Report players includes numerous prominent players like Stryker Corporation (U.S.), Johnson & Johnson (U.S.), Abbott Laboratories (U.S.), Genentech, Inc. (U.S.), Merck & Co., Inc. (U.S.), Sanofi (France), Bayer AG (Germany), Koninklijke Philips N.V. (Netherland), Boston Scientific Corporation (U.S.), Medtronic plc (U.S.), Siemens Healthcare (U.S.), Pfizer Inc. (U.S.), GE Healthcare (U.S.), Covidien PLC (Ireland), GE Healthcare (U.S.), Philips Healthcare (U.S.), Hitachi, Ltd (Japan), Boehringer Ingelheim (Germany), Penumbra, Inc. (U.S.), Cordis Corporation (U.S.), Daiichi Sankyo (U.S.), Biogen (U.S.), and others.

Market Segmentation

The Global Ischemic Stroke Market Outlook segmentation is based on key dynamics like drug class, diagnosis, end-users, and surgery. 

·         By drug class, the market segments into anticoagulant, tissue plasminogen activator, antihypertensive, antiplatelet, and others. 

·         By diagnosis, the market includes carotid ultrasound Computed Tomography (CT), echocardiography, cerebral angiography, Magnetic resonance imaging (MRI), electrocardiography, and others.

·         By end-user, the market comprises of medical institutes, research organizations, hospitals & clinics, and others.

·         By surgery, the market divides into endovascular mechanical thrombectomy, carotid endarterectomy, and angioplasty.

Regional Analysis 

The Global Ischemic Stroke Market Overview is geographically segmented into the following regions: Asia Pacific, America, Europe, and the Middle East and Africa. 

The Americas is reported to be the largest market for ischemic stroke due to technological innovations, favorable government initiatives, and rising demand for ischemic stroke products. 

Europe holds the second largest share of the market and is expected to hold on to the same in the forthcoming years due to numerous factors. Rising prevalence of acute ischemia stroke cases and advancements in the surgical device technology are two key factors driving the market herein. Other driving factors of the market in this region is the growing number of diabetes mellitus population primarily in the developed nations of Europe. 

Asia Pacific is identified to witness the most promising growth in the forecast period to cement its place in the global ischemic stroke market. The proliferating growth of the region can be attributed to the widespread prevalence of stroke cases in the Asia Pacific region. Both China and India are two of the major contributors to the regional market and will play major roles in accelerating the overall Asia Pacific region. Manufacturers are quickly realizing the potential this region holds and are expanding their operations therein to capitalize on the same. 

The Middle East region is anticipated to grow at a fast rate owing to factors like increasing emphasis on research and development activities in the healthcare sector and continuous development of the healthcare infrastructure. 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Smart Contact Lenses Market Overview Analysis 2032: In-Depth Research on Industry Size, Current and Emerging Growth Factors by 2032

Market Overview

Smart contact lenses are implemented with sensors, which detect intraocular pressure and glucose levels in tears. With smart devices gaining immense popularity across the world due to several benefits like constant monitoring of health indicators, smart contact lenses have emerged as an important device. Smart contact received the U.S. approval in August 2015 for monitoring intraocular pressure. The global smart contact lenses market share is expected to register a CAGR of 9.3%, surpassing a valuation of USD 10.7 billion during the forecast period (2023-2032).

Smart contact lenses comprise a miniaturized glucose sensor and a wireless chip. The tiny pinhole present in the lens enables tear fluid to ooze out into the sensor and measure blood sugar level. The smart contact lenses market overview is gaining traction across the globe, mainly due to the rising incidence of diabetes, replacement of smart glasses by smart lenses, changing trends identified in eyewear, and increased demand of wearable medical devices. Moreover, the key players involved in the market are highly engaged in the development of innovative products, which helps them to withstand their position in the market.

The surging demand for more efficient glaucoma management approaches will encourage the market growth in the coming years. Also, advancements in ophthalmology are estimated to augment the product demand. The rising incidence of diabetes-related complications like ophthalmology, and eye disorders, and surging prevalence of glaucoma will contribute to the market growth across the globe.

On the contrary, smart contact lenses are expensive, which can slow down its growth in the foreseeable future.

Competitive Dashboard

Smart Contact Lenses Market Players operating in the smart contact lenses market include

·         Sony (Japan),

·         Samsung (South Korea),

·         Google (U.S), Alcon (U.S), and

·         Sensimed SA (Switzerland).

 

Global Smart Contact Lenses Market: Segmental Analysis

By application, the Smart Contact Lenses market report is segmented into intraocular pressure monitoring, continuous glucose monitoring, and others. Of these, continuous glucose monitoring segment is predicted to gain prominence. Smart contact lenses with microsensor that constantly measures glucose level can act as a life-changing technology and works by measuring glucose concentration with the enzymatic sensor, which is directly connected to miniaturized electronic circuits.

The end user segment comprises clinics, hospitals, and home care settings.

Regional Frontiers

Based on the region, the smart contact lenses market trends covers growth opportunities and the latest trends across the Americas, Asia Pacific, Europe, and the Middle East & Africa.

Considering the global scenario, the Americas command the largest market share for smart contact lenses due to the surging diabetic population in the region. The surging adoption of upgraded wearable medical devices and soaring demand for eye care solutions are considered to elevate the scope of the regional market. In this region, North America is considered to be the major contributor due to several factors like the high availability of a wide range of products, existence of international brands offering innovative products, and high consumer awareness regarding these products.

Europe has managed to seize the second-largest share globally, and the growth can be mainly credited to the surge in expenditure on research in smart medical devices. High use of smart contact lenses in the nations of the region is likely to foster the market growth in the coming years.

Rising cases of chronic diseases, for instance, diabetes is higher in the Asia Pacific region, which creates growth opportunities for the market. The region shows a sluggish growth as smart medical devices are not affordable for most of the countries. Moreover, people are not aware of such devices, which further curbs the market growth.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Process Analytical Technology Market Overview by Size, Share, Trends, Growth and Competitive landscape 2032

 

Market summery

The Process Analytical Technology Market Overview is projected to reach at 13.1% CAGR during the forecast period 2023-2032. The FDA defines process analytical technology (PAT) as a mechanism for designing, studying, and controlling pharmaceutical manufacturing processes by measuring essential process parameters that affect critical quality attributes of an active pharmaceutical component (API). The primary goal of process analytical technology is to reduce production cycling time, batch rejection and maximize automation. According to a report published by MRFR, the market is estimated to accomplish a formidable CAGR in the duration of the forecast period.

Process Analytical Technology Industry have played an essential role in the pharmaceutical industry's process development and scale-up of asymmetric syntheses of chiral compounds, including active medicinal ingredients. The necessity for automation and quality control in pharmaceutical manufacturing and escalating regulatory restrictions for drug manufacture and pharmaceutical production are powerful factors for the use of the process analytics sensors.

Competitive Analysis

Due to the return of COVID cases in many locations, the market may exhibit constrained growth. The continuation of occasional lockdowns in numerous regions may cause the market expansion to be hampered if resources such as labor and supply chains are severely impacted. The global market is expected to diversify in operational techniques as innovative models for operation and delivery are implemented. It is projected that the emphasis on accumulating reserves of resources to deal with unexpected crises would impact future market trends. Government assistance is expected to support worldwide market development in the next years. Market developments and research are expected to generate attractive growth opportunities in the next years. The reliance on online commerce for sales is expected to increase significantly during the forecast period, prompting market stakeholders to invest more in its growth.

The Process Analytical Technology Market Players are

·          PerkinElmer, Inc. (U.S.),

·          Thermo Fisher Scientific, Inc. (U.S.),

·          Agilent Technologies, Inc. (U.S.),

·          Bruker Corporation (U.S.), and

·          Danaher Corporation (U.S.).

Segmental Analysis

The segmentation of the Process Analytical Technology Market Report is conducted on the basis of product, region, and application.

Based on application, the process analytical technology market consists of spectroscopy which is further segmented into molecular, mass, and atomic spectroscopy, chromatography which is further segmented into liquid and gas; electrophoresis, and particle size analysis.

The process analytical technology market consists of a sensor, probes, and analyzers based on product. Based on regions, the process analytical technology market consists of North America, Europe, Asia-Pacific, and other global markets.

Detailed Regional Analysis 

The regional assessment of the Process Analytical Technology Market Outlook consists of North America, Europe, Asia-Pacific, and other global markets. During the projected period, North America is estimated to account for the greatest share of the market. The presence of a large number of market participants and regulatory compliance pushing the use of PAT are fueling the growth of the North American market. However, the Asia-Pacific region is expected to increase the most during the forecast period. The Asia-Pacific market for process analytical technology has increased dramatically in recent years, owing to increased government funding in the biotech industry, an increase in the number of contract research and manufacturing institutions, and an increased focus of international players on emerging markets.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Biologic Therapy Market Overview Trends, Recent Developments and Technology, Size, Share, Future Growth, Forecast Research Report 2030

 

Global Biologic Therapy Market to Grow Healthily over 2023

Biologic therapy is gaining traction. According to a report published by Market Research Future (MRFR), the global biologic therapy market share is set to reach USD 288.03 billion by 2030 at a CAGR 8.20% over the forecast years 2023-2030. Biologic therapy is viewed as an innovative treatment module based on products sourced from living organisms.

Biologic therapy is used to stimulate or suppress the immune system for treatment purposes. The therapy finds application in treatment of diseases such as infection, cancer and several other diseases. Advances in the field of biologic therapeutic is boosting the application scope of biologic therapy. Rising demand for biological and targeted drug therapies is making a positive impact on the global biological therapy market overview. The R&D pipeline for biologic therapy is expected to grow in the future as pharmaceutical companies realise the vast market opportunities. 

Global Biologic Therapy Market: Competition Analysis

Global biologic therapy market players include Bristol-Myers Squibb, Amgen Inc., Eli Lilly, Seattle Genetics, Inc., GlaxoSmithKline Plc., Novartis International AG, Celgene Corporation and Spectrum Pharmaceuticals, Inc.

Global Biologic Therapy Market: Segmental Analysis

MRFR’s report includes a detailed segmental analysis of the market based on therapy, product type, end-user and application. Based on therapy, the market has been segmented into vaccines therapy, cell therapy, protein therapy and others. Based on product type, the market has been segmented into services, instruments and kit and reagents. Based on end-user, the market has been segmented into hospitals and clinic, research centers and speciality centers. Based on application, the market has been segmented into blood and blood-related products testing, tissue and tissue-related products testing, vaccine and therapeutics development, stem cell research and cellular and gene therapy.

Global Biologic Therapy Market: Regional Analysis

On the basis of region, the biologic therapy market report has been segmented into North America, Europe, the Middle East & Africa (MEA), Latin America and Asia Pacific (APAC). North America represents an important market for biologic therapy. Rising geriatric population, growing cancer prevalence in countries such as the U.S. and Canada are some of the factors supporting the market growth in the region. Data released by United States Census Bureau reveals that the total count of Americans aged 65 and above surpassed 49.2 Mn in 2016. Advanced countries in North America have robust health coverage policies along with a quicker access to latest biologic therapeutics. Many market players operating in North America are focusing on patient-centric products. In addition, companies are focusing on delivering customized therapeutics. High healthcare spending in the region is also influencing the market growth. The Center for Disease Control and Prevention reported that healthcare expenditure in the U.S reach to 3.2 trillion in 2015.

Europe in hold the second spot in the global biologic therapy market outlook in terms of revenue. The market in Europe is expected to exhibit a healthy growth over the next couple of years. The healthcare sector remains focused on innovation and continue to excel in delivering quality care. In addition, presence of an advanced healthcare system is reflecting favourably on the market in the region. Many of the advanced countries in Europe have large pool of geriatric population. Data released by Eurostat revealed that more that 19% of the over population in Europe is aged 65 and above.

Asia Pacific is emerging as a highly attractive market for biologic therapy. It is projected that the market in APAC will demonstrate the fastest growth during the forecast period. Increased occurrence of lifestyle diseases is driving the demand for biologic therapy. Rising healthcare expenditure, increased awareness level and improving healthcare infrastructure are some of the key factors influencing the market in APAC.

The market in MEA is expected to witness a relatively slower growth during the forecast period. This is mainly owing low penetration and limited access. However, increased efforts towards improving healthcare standard in GCC countries is likely to create market opportunities.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Laboratory Information Systems Market by Size, Share, Trends, Competitive Landscape, Regional Analysis Forecasts to 2030

 

Market Scenario

The global laboratory information systems share is projected to grow USD 3.8694 billion by 2030 at CAGR of 9.50% during the forecast period 2023-2030, predicts Market Research Future (MRFR). There are several practice applications of an LIS that improve the day-to-day operations of a medical laboratory, along with prevention of medical errors. A busy medical laboratory having many patients on a regular basis encounter difficulty in keeping all the patients’ information organized. Thus, an LIS system comes in handy, as it helps keep all this information organized, which is vitally important for a medical lab to run smoothly. Apart from this, rising integration of LIS and Electronic Health Record (EHR) and demand for quality and precision diagnosis are majorly supplementing the market growth globally. Moreover, increasing penetration of mobile applications in healthcare solutions coupled with growing popularity of cloud-based laboratory information system testifies for the market progress that has taken place in the past few years.

On the flip side, lack of skilled information technology (IT) professionals in the healthcare industry tames the flow of the progressing Laboratory Information Systems Market Report. However, an array of opportunities stemming from emerging regions along with the consistently growing adoption of LIS are proof enough that the global market is en-route to brighter future prospects. Also noteworthy are few trends that bestow the global market with the required push, including proliferation of smartphones, point-of-care devices and e-services in the healthcare industry which significantly shape the market dynamics. Also, immense demand from patients for technological solutions for more convenient health testing, and monitoring is growing. This leads to global market players taking notice of the opportunities that crop up and indulge in strategic activities such as product launches. For instance, in the year 2014, Thermo Fisher launched a new ultracentrifuge which combines speed with safety and ergonomics that allows researchers to protect samples easily while also achieving reliable and consistent results.

Key Players

global laboratory information systems market players include   Cerner Corporation, Recent Developments, Eclipsys Corporation, Merge Healthcare Inc., STARLIMS Corporation, Sunquest Corporation and Thermo Fisher Scientific Inc., LabVantage Solutions Inc., LabWare Inc., McKesson Corporation, Medical Information Technology Inc., and others.

The Cerner EHR project is thriving as the U.S. Department of Defense increases its budget by about USD 1.2 billion. The additional funds will support the added services to maintain a standard EHR between the Department of Veterans Affairs and the U.S. Coast Guard. The EHR when integrated with laboratory information system, turns highly efficient, which leads to increased productivity and also reduced probability of errors. Cerner is an established company in the global LIS market that understands this fact and makes use of every opportunity to enhance its products to cater to various customer needs.

Market Segmentation

The global laboratory information systems market overview is segmented on the basis of application, components, and delivery.

By applications, the market is segmented based on clinical LIS, drug discovery LIS, and industrial LIS. The clinical application of LIS holds the largest market share as using LIS software involves more productivity and less paperwork, enhanced patient safety, and improved turn-around time.

By components, the market is segmented based on software, hardware, and services. Among these, the software segment accounts for the majority of the global LIS market due to increasing product enhancements and advent of innovative LIS software systems which ensures the smooth running of the healthcare department.

By delivery, the market is segmented on the basis of web-based, on-premise and cloud-based. Among these, cloud-based LIS software is highly popular as it offers various benefits such as cost savings, high security, flexibility, mobility and quality control.

Regional Analysis

By region, the global laboratory information systems market insights is segmented on the basis of North America, Europe, Asia Pacific and the Rest of the World (RoW).

The joint market share combining North America and Europe was more than 75% of the global total market size in 2014. However, North America has currently secured the top position claiming the largest market share. This stupendous growth can be attributed to increasing cases of fatal diseases and subsequent diagnostic and treatment needs. Moreover, high disposable income and strong economy also help augment the market growth in the region. Furthermore, increasing business opportunities for healthcare service providers along with growing demand for automated instruments rising in laboratories has majorly triggered the market growth in the region.

On the other hand, the Europe LIS market is estimated to grow tremendously during the forecast period, due to massive investment by healthcare IT players and a barrage of players trying to enter the regional market and establish themselves. Moreover, thriving healthcare industry and sophisticated medical infrastructure also play a major role in the growth of the regional market.

The Asia-marked Pacific is also presumed to grow at a significant pace throughout the forecast period. This growth is due to increased infectious diseases, significant increase in healthcare expenditure and advancements in healthcare IT sector. The market growth in the region is also aided by growing need for enhancing the efficiency of medical laboratories, growing demand for error-free diagnosis and increasing integration of information system with laboratories.

The rising aging population and increasing cases of fatal diseases in the regions of Middle East and Africa have propelled the market growth in the region. Also, the market in the region is highly fragmented, and the regional market players used various strategies such as product launches, expansions, and joint ventures to increase their footprint in the region. This gives a significant push to the market and will continue to do so in the coming years as well.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Tumor Ablation Market to Be Driven by Rising Use For Observation, Data Collection, And Intelligence In The Forecast Period Of 2023-2032

Market Overview

 The tumor ablation market is a rapidly growing market that is expected to reach a value of $4.07 billion by 2030. Tumor ablation is a minimally invasive procedure that uses heat, cold, or other energy to destroy cancer cells. It is a less invasive alternative to surgery and can be used to treat tumors in a variety of locations, including the liver, kidney, lung, and prostate.

Key Players

The tumor ablation market players include:

• Medtronic Plc
• Boston Scientific Corporation
• AngioDynamics Inc.
• Abbott
• Merit Medical Systems
• Galil Medical, Inc.
• EDAP TMS SA
• Hologic Inc.
• SonaCare Technologies, Inc.
• AtriCure, Inc.

These companies offer a variety of tumor ablation devices and technologies.

There are a number of factors driving the growth of the tumor ablation market, including:

• Rising prevalence of cancer: The global cancer incidence is expected to reach 23.6 million cases by 2030. This increase in cancer cases is driving the demand for minimally invasive treatment options such as tumor ablation.
• Improvements in technology: Technological advancements in tumor ablation devices are making the procedures more effective and safer. For example, new ultrasound-guided tumor ablation devices allow doctors to precisely target tumors with heat energy.
• Preference for minimally invasive procedures: Patients are increasingly preferring minimally invasive procedures over surgery due to the shorter recovery time and lower risk of complications.
• Cost-effectiveness: Tumor ablation is a cost-effective treatment option for many patients, especially those who are not good candidates for surgery.

The tumor ablation market is segmented by technology, treatment, application, and region. The technology segment is further segmented into radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation, irreversible electroporation ablation (IRE), and others. The treatment segment is further segmented into surgical ablation, laparoscopic ablation, and percutaneous ablation. The application segment is further segmented into kidney cancer, liver cancer, breast cancer, lung cancer, and prostate cancer. The region segment is further segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America is the largest market for tumor ablation, followed by Europe and Asia Pacific. This is due to the high prevalence of cancer and the availability of advanced technology in these regions. The Asia Pacific region is expected to grow at the fastest CAGR during the forecast period, due to the increasing incidence of cancer and the growing demand for minimally invasive procedures in this regions

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Service

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Corporate Wellness Market Players, Segmentation, Analysis by Recent Trends, Future Prospects, Growth, Development by Regions to 2032

Market Insights

The corporate wellness market size is a rapidly growing industry that provides a variety of services and programs designed to improve the health and well-being of employees. The market is expected to reach a value of \$74.9 billion by 2030, growing at a CAGR of 4.47% from 2023 to 2030.

There are a number of factors driving the growth of the corporate wellness market, including:

• Rising awareness of the importance of employee health and well-being: Employers are increasingly recognizing the link between employee health and productivity. Studies have shown that unhealthy employees are more likely to miss work, take sick days, and have accidents. This can lead to significant financial losses for employers.
• Increased prevalence of chronic diseases: Chronic diseases such as obesity, heart disease, and diabetes are on the rise in the workplace. These diseases can lead to high healthcare costs for employers. Corporate wellness programs can help employees prevent chronic diseases and manage their health conditions, which can save employers money.
• Technological advancements: Technological advancements have made it easier to deliver corporate wellness programs to employees. For example, mobile apps and wearable devices can be used to track employee health data and provide personalized coaching and support.
• Changing workforce demographics: The workforce is becoming more diverse, with a growing number of employees from different cultures and backgrounds. This makes it important for employers to offer corporate wellness programs that are tailored to the needs of their employees.

Segmentation

The corporate wellness market is segmented by service, delivery mode, end-user, and region. The service segment is further segmented into health risk assessment, health coaching, fitness and wellness programs, disease management, and others. The delivery mode segment is further segmented into on-site, off-site, and virtual. The end-user segment is further segmented into large enterprises, small and medium-sized enterprises (SMEs), and government organizations. The region segment is further segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America is the largest market for corporate wellness, followed by Europe and Asia Pacific. This is due to the high awareness of the importance of employee health and well-being in these regions. The Asia Pacific region is expected to grow at the fastest CAGR during the forecast period, due to the increasing investment in corporate wellness by employers in this region.

Key Players

The corporate wellness market players include:

• Wellness Corporate Solutions, LLC
• EXOS
• ComPsych Corporation
• Virgin Pulse Inc.
• Welltok, Inc.
• LifeWorks, Inc.
• Healthways, Inc.
• Aetna Inc.
• Cigna Corporation
• UnitedHealth Group Inc.
• Humana Inc.

These companies offer a variety of services and programs to help employers improve the health and well-being of their employees.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013